👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

U.S. Congress reaches deal on COVID-19 aid package, plans votes for Monday

Published 12/20/2020, 01:18 AM
Updated 12/21/2020, 12:01 AM
© Reuters. The U.S. Capitol dome is seen at night in Washington

By Andy Sullivan and David Shepardson

WASHINGTON (Reuters) -U.S. congressional leaders reached agreement on Sunday on a $900 billion package to provide the first new aid in months to an economy and individuals battered by the surging coronavirus pandemic, with votes likely on Monday.

The package would be the second-largest economic stimulus in U.S. history, following a $2.3 trillion aid bill passed in March. It comes as the pandemic accelerates, infecting more than 214,000 people in the country each day. More than 317,000 Americans have already died.

"At long last, we have the bipartisan breakthrough the country has needed," Republican Senate Majority Leader Mitch McConnell said on the Senate floor, following months of contentious debate.

Republican and Democratic leaders said the package should have enough support to pass both chambers of Congress.

President Donald Trump supports the bill and will sign it into law, White House spokesman Ben Williamson said.

The package would give $600 direct payments to individuals and boost unemployment payments by $300 a week. It also includes billions for small businesses, food assistance, vaccine distribution, transit and healthcare. It extends a moratorium on foreclosures and provides $25 billion in rental aid.

"Anyone who thinks this bill is enough does not know what's going on in America," Democratic Senate leader Chuck Schumer said at a news conference. He said he would push for more aid after Democratic President-elect Joe Biden takes office on Jan. 20.

Lawmakers said they had resolved disputes over the Federal Reserve's pandemic lending authority and other issues that had forced negotiations into the weekend.

The Democratic-led House of Representatives will likely vote on the package on Monday, with the Republican-controlled Senate to follow, according to House Democratic leader Steny Hoyer.

Congress aims to include the coronavirus aid package in a $1.4 trillion spending bill funding government programs through September 2021.

That funding was due to expire at midnight Sunday (0500 GMT Monday). The House and the Senate both voted to extend funding through Monday, buying more time to pass the coronavirus package and the larger government spending bill. Trump signed the extension into law.

STICKING POINTS OMITTED

The relief bill leaves out two of the most contentious elements in the negotiations: legal protections for businesses from coronavirus lawsuits, which had been sought by Republicans, and the substantial aid for state and local governments advocated by Democrats.

But the package helps state and local governments indirectly by providing billions for schools, coronavirus testing and other expenses, Schumer said.

It also includes elements unrelated to the pandemic: a bipartisan provision that aims to end surprise medical billing, and one that authorizes flood control and other water-related projects.

The bill would allow Federal Reserve emergency lending programs to expire on Dec. 31 for businesses and state and local governments, which Republicans said were an unnecessary government interference in private business. But it does not prevent similar programs from being created.

The pandemic will stand as the largest crisis facing Biden's new administration, although signs of hope have emerged as the United States has begun vaccinating people against the highly contagious respiratory disease.

© Reuters. US Capitol Senate Voting on Coronavirus package

In the 11 months since the first cases of the new coronavirus were documented in the United States, COVID-19 has put millions of Americans out of work, with unemployment rising. Economists say growth will likely remain sluggish until vaccines are widely available in mid-2021. (Graphic: https://tmsnrt.rs/34pvUyi)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.